We analyze the impact of national pharmaceutical regulation on the launch delay of new chemical entities approved by the EMEA’s centralized...

To win the critical race between vaccines and mutations, the worldwide vaccination Covid-19 campaign must mobilise economies of scale. The...

SARS-Cov-2, das die potenziell tödliche Krankheit Covid-19 auslösende Virus, scheint umso gefährlichere Mutationen zu bilden, je weiter es...

In a Kiel Focus article Michael Stolpe suggests to use patent buy-outs to vaccinate the world.

hosted by Japan’s Ministry of Finance, the International Monetary Fund and the Asian Development Bank

Kiel Policy Brief No. 87: Germany is chairing the G7 this year and has prioritized global health as one of the key issues on the G7 agenda.

The present paper deals with a topic that pertains to Health Economics as well as to Trade Theory – Trade in Health Services. It is intended...

This paper examines the role of the health gradient – the positive correlation between household income and health – in individual retirement...

This paper provides micro-econometric evidence on the relevance of non-market interaction for the timing of initial public offerings (IPOs) in...

This paper develops a real options approach to the optimal sequencing of antiretroviral drug cocktails for HIV/AIDS patients in resource-poor...

This paper provides new evidence on Europe's experience with venture capital in the 1990s. Individual countries' activity is not solely...

This paper analyses the efficiency of venture capital and its impact on primary equity markets in France and Germany. It shows that venture...

This paper evaluates the evolution of European venture capital investments since 1990, using the distribution dynamics methodology. It tests...